Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Structural heart occluders are used for the treatment of congenital heart defects by closing openings in the heart. Structural heart occluders cover left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, and patent ductus arteriosus closure devices.
The structural heart occluders pipeline market research report provides comprehensive information about the structural heart occluders pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Structural Heart Occluders Pipeline Products Market Segments
The key segments in the structural heart occluders pipeline products market are left atrial appendage closure devices, patent foramen ovale closure devices, atrial septal defect occluders, and ventricular septal defect occluders. Left atrial appendage closure devices have the highest number of products in the structural heart occluders pipeline products market.
Structural Heart Occluders Pipeline Products Market Analysis by Segments, 2022 (%)
For more insights into the structural heart occluders pipeline products market segments, download a free report sample
Structural Heart Occluders Pipeline Products Market Segmentation, by Territories
Some of the key territories with structural heart occluders products in the pipeline are the United States, Europe, Global, China, Canada, Japan, South Korea, El Salvador, Costa Rica, and others. As of November 2022, the US has the highest number of products in the pipeline out of them all.
Structural Heart Occluders Pipeline Products Market Analysis, by Territories, 2022 (%)
For more territory insights into the structural heart occluders pipeline products market, download a free report sample
Structural Heart Occluders Pipeline Products Market Segmentation by Regulatory Paths
Some of the key regulatory paths followed by the structural heart occluders pipeline products market are PMA, NMPA, CE, Shonin, MDL, NIFDS, HAS, ICAC, and MDA. Most of the products follow the PMA pathway to enter the market.
Structural Heart Occluders Pipeline Products Market Analysis, by Regulatory Paths, 2022 (%)
For more structural heart occluders pipeline products regulatory path insights, download a free report sample
Structural Heart Occluders Pipeline Products Market - Competitive Landscape
Some of the leading companies in the structural heart occluders pipeline products market are Aegis Medical Innovations Inc., Aporo Biomedical, Inc. (Inactive), Append Medical, atHeart Medical, AuriGen Medical Ltd, Boston Scientific Corp, CARAG AG, Cierra, Inc. (Inactive), Conformal Medical Inc, and Cor Habere Corp.
Structural Heart Occluders Pipeline Products Market Report Overview
| Key Segments | Left Atrial Appendage Closure Devices, Patent Foramen Ovale Closure Devices, Atrial Septal Defect Occluders, and Ventricular Septal Defect Occluders |
| Analysis Year | 2022 |
| Key Territories | The United States, Europe, Global, China, Canada, Japan, South Korea, El Salvador, Costa Rica, and Others |
| Key Regulatory Paths | PMA, NMPA, CE, Shonin, MDL, NIFDS, HAS, ICAC, and MDA |
| Leading Companies | Aegis Medical Innovations Inc., Aporo Biomedical, Inc. (Inactive), Append Medical, atHeart Medical, AuriGen Medical Ltd, Boston Scientific Corp, CARAG AG, Cierra, Inc. (Inactive), Conformal Medical Inc, and Cor Habere Corp. |
Structural Heart Occluders Pipeline Products Market Segments Outlook (2022)
- Left Atrial Appendage Closure Devices
- Patent Foramen Ovale Closure Devices
- Atrial Septal Defect Occluders
- Ventricular Septal Defect Occluders
Structural Heart Occluders Pipeline Products Market Territories Outlook (2022)
- The United States
- Europe
- Global
- China
- Canada
- Japan
- South Korea
- El Salvador
- Costa Rica
- Others
Structural Heart Occluders Pipeline Products Market Regulatory Paths Outlook (2022)
- PMA
- NMPA
- CE
- Shonin
- MDL
- NIFDS
- HAS
- ICAC
- MDA
Scope
This report provides:
- Extensive coverage of the structural heart occluders under development.
- Details of major structural heart occluders pipeline products which include product description, licensing, collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.
- Reviews of the major players involved in the development of structural heart occluders and list all their pipeline projects.
- The coverage of structural heart occluders pipeline products based on various stages of development ranging from early development to the approved/issued stage.
- Key clinical trial data of ongoing trials specific to structural heart occluders pipeline products.
- Recent Developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
- Identify and understand important and diverse types of structural heart occluders under development.
- Develop market-entry and market expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Key Players
Table of Contents
List of Tables
List of Figures
Frequently Asked Questions
The key segments in the structural heart occluders products pipeline market are left atrial appendage closure devices, patent foramen ovale closure devices, atrial septal defect occluders, and ventricular septal defect occluders.
The United States, Europe, Global, China, Canada, Japan, South Korea, El Salvador, Costa Rica, and others are some of the key territories with structural heart occluders in the pipeline.
The US leads the structural heart occluders pipeline market in terms of the number of products.
Some of the key regulatory paths followed by the structural heart occluders pipeline products market are PMA, NMPA, CE, Shonin, MDL, NIFDS, HAS, ICAC, and MDA.
Most of the products follow the PMA pathway to enter the structural heart occluders market.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
